Megan Anderson launches book on neurodiversity in women

Author and AI entrepreneur Megan Anderson is spotlighting the overlooked diagnosis of ADHD and autism in women and girls with a new book, Chameleon: Masking in Women on the Spectrum. The book is out as an ebook now and frames late diagnosis as a health care gap that leaves many women unheard.

Why it matters: - Megan Anderson’s new book targets a long-running blind spot in health care: ADHD and autism often look different in women and girls, and many are diagnosed late or not at all. - The book argues that missed recognition can leave women searching for answers for years while being misread by doctors, schools and families. - Anderson frames the issue as both a medical and social problem, with implications for screening, education and support.

What happened: - Megan Anderson released Chameleon: Masking in Women on the Spectrum as an ebook, with full retail editions coming soon. - Anderson is using the book to push awareness of how neurodiversity can present differently across the lifetime in females. - The launch comes from Melbourne, Florida, where Anderson is based.

The details: - Chameleon examines masking, late diagnosis and the myths that often surround ADHD and autism in women. - Anderson says many women seeking help are given other labels first instead of deeper screenings that could identify neurodiversity. - The book argues that descriptions such as “atypical presentations” often reflect a research gap rooted in the historical focus on male presentations. - Anderson says the public and the medical establishment need to do a better job of believing women about what they experience in their own minds and bodies. - The book is dedicated to women who went unnoticed for decades while research and clinical attention centered on males. - Anderson says the book is meant to help educate the public, teachers and medical professionals about the nuances of neurodiversity in women.

Between the lines: - Anderson is positioning the book as advocacy, not just commentary. - The release links women’s health, neurodiversity and trust in medical systems, which suggests the core message is about diagnosis as much as identity. - Her framing also reflects a broader shift in public discussion: more women are questioning whether they were overlooked, misdiagnosed or dismissed earlier in life.

What’s next: - Full retail editions of Chameleon are expected soon. - Anderson is likely to keep using her platform to promote neurodiversity awareness, child safety and ethical technology. - More public attention to late diagnosis could increase demand for screening, education and support services tailored to women and girls.

The bottom line: - Chameleon turns a personal and clinical problem into a public call for better listening, better research and better diagnosis for women and girls.